Medically, the use of microorganisms to treat diseases in patients with diseases is called microbial treatment.
The report focuses on the Microbiome Therapeutics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Microbiome Therapeutics market.
Major Players in the Microbiome Therapeutics market are:
Synthetic Biologics
AOBiome
OpenBiome
Seres Therapeutics
Interxon
Assembly Biosciences
Enterome BioScience
Rebiotix
4D Pharma
Metabogen
Symberix
C3 Jian
Osel
Azitra
MicroBiome Therapeutics LLC
Ritter Pharmaceuticals
Synlogic
Metabiomics
Symbiotix Biotherapies
Second Genome
PureTech
On the basis of types, the Microbiome Therapeutics market is primarily split into:
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Inulin
On the basis of applications, the market covers:
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Microbiome Therapeutics Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Microbiome Therapeutics Market Overview
1.1 Product Overview and Scope of Microbiome Therapeutics Market
1.2 Microbiome Therapeutics Market Segment by Type
1.2.1 Global Microbiome Therapeutics Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Microbiome Therapeutics Market Segment by Application
1.3.1 Microbiome Therapeutics Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Microbiome Therapeutics Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Microbiome Therapeutics (2017-2029)
1.5.1 Global Microbiome Therapeutics Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Microbiome Therapeutics Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Microbiome Therapeutics Industry
1.7 Impact of Carbon Neutrality on the Microbiome Therapeutics Industry
2 Microbiome Therapeutics Market Upstream and Downstream Analysis
2.1 Microbiome Therapeutics Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Microbiome Therapeutics Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Synthetic Biologics
3.1.1 Synthetic Biologics Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Microbiome Therapeutics Market Performance (2017-2022)
3.1.4 Business Overview
3.2 AOBiome
3.2.1 AOBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Microbiome Therapeutics Market Performance (2017-2022)
3.2.4 Business Overview
3.3 OpenBiome
3.3.1 OpenBiome Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Microbiome Therapeutics Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Seres Therapeutics
3.4.1 Seres Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Microbiome Therapeutics Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Interxon
3.5.1 Interxon Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Microbiome Therapeutics Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Assembly Biosciences
3.6.1 Assembly Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Microbiome Therapeutics Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Enterome BioScience
3.7.1 Enterome BioScience Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Microbiome Therapeutics Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Rebiotix
3.8.1 Rebiotix Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Microbiome Therapeutics Market Performance (2017-2022)
3.8.4 Business Overview
3.9 4D Pharma
3.9.1 4D Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Microbiome Therapeutics Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Metabogen
3.10.1 Metabogen Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Microbiome Therapeutics Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Symberix
3.11.1 Symberix Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Microbiome Therapeutics Market Performance (2017-2022)
3.11.4 Business Overview
3.12 C3 Jian
3.12.1 C3 Jian Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Microbiome Therapeutics Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Osel
3.13.1 Osel Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Microbiome Therapeutics Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Azitra
3.14.1 Azitra Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Microbiome Therapeutics Market Performance (2017-2022)
3.14.4 Business Overview
3.15 MicroBiome Therapeutics LLC
3.15.1 MicroBiome Therapeutics LLC Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Microbiome Therapeutics Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Ritter Pharmaceuticals
3.16.1 Ritter Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Microbiome Therapeutics Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Synlogic
3.17.1 Synlogic Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Microbiome Therapeutics Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Metabiomics
3.18.1 Metabiomics Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Microbiome Therapeutics Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Symbiotix Biotherapies
3.19.1 Symbiotix Biotherapies Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Microbiome Therapeutics Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Second Genome
3.20.1 Second Genome Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Microbiome Therapeutics Market Performance (2017-2022)
3.20.4 Business Overview
3.21 PureTech
3.21.1 PureTech Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Microbiome Therapeutics Market Performance (2017-2022)
3.21.4 Business Overview
4 Global Microbiome Therapeutics Market Landscape by Player
4.1 Global Microbiome Therapeutics Sales and Share by Player (2017-2022)
4.2 Global Microbiome Therapeutics Revenue and Market Share by Player (2017-2022)
4.3 Global Microbiome Therapeutics Average Price by Player (2017-2022)
4.4 Global Microbiome Therapeutics Gross Margin by Player (2017-2022)
4.5 Microbiome Therapeutics Market Competitive Situation and Trends
4.5.1 Microbiome Therapeutics Market Concentration Rate
4.5.2 Microbiome Therapeutics Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Microbiome Therapeutics Sales, Revenue, Price Trend by Type
5.1 Global Microbiome Therapeutics Sales and Market Share by Type (2017-2022)
5.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2017-2022)
5.3 Global Microbiome Therapeutics Price by Type (2017-2022)
5.4 Global Microbiome Therapeutics Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate of Fructo-Oligosaccharides (2017-2022)
5.4.2 Global Microbiome Therapeutics Sales, Revenue and Growth Rate of Galacto-Oligosaccharides (2017-2022)
5.4.3 Global Microbiome Therapeutics Sales, Revenue and Growth Rate of Inulin (2017-2022)
6 Global Microbiome Therapeutics Market Analysis by Application
6.1 Global Microbiome Therapeutics Consumption and Market Share by Application (2017-2022)
6.2 Global Microbiome Therapeutics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Microbiome Therapeutics Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Microbiome Therapeutics Consumption and Growth Rate of Inflammatory Bowel Disease (IBD) (2017-2022)
6.3.2 Global Microbiome Therapeutics Consumption and Growth Rate of Orphan Drug (2017-2022)
6.3.3 Global Microbiome Therapeutics Consumption and Growth Rate of Immuno-oncology (2017-2022)
7 Global Microbiome Therapeutics Sales and Revenue Region Wise (2017-2022)
7.1 Global Microbiome Therapeutics Sales and Market Share, Region Wise (2017-2022)
7.2 Global Microbiome Therapeutics Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Microbiome Therapeutics Market Forecast (2022-2029)
8.1 Global Microbiome Therapeutics Sales, Revenue Forecast (2022-2029)
8.1.1 Global Microbiome Therapeutics Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Microbiome Therapeutics Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Microbiome Therapeutics Price and Trend Forecast (2022-2029)
8.2 Global Microbiome Therapeutics Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.3 China Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.5 India Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Microbiome Therapeutics Sales and Revenue Forecast (2022-2029)
8.3 Global Microbiome Therapeutics Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Microbiome Therapeutics Revenue and Growth Rate of Fructo-Oligosaccharides (2022-2029)
8.3.2 Global Microbiome Therapeutics Revenue and Growth Rate of Galacto-Oligosaccharides (2022-2029)
8.3.3 Global Microbiome Therapeutics Revenue and Growth Rate of Inulin (2022-2029)
8.4 Global Microbiome Therapeutics Consumption Forecast by Application (2022-2029)
8.4.1 Global Microbiome Therapeutics Consumption Value and Growth Rate of Inflammatory Bowel Disease (IBD) (2022-2029)
8.4.2 Global Microbiome Therapeutics Consumption Value and Growth Rate of Orphan Drug (2022-2029)
8.4.3 Global Microbiome Therapeutics Consumption Value and Growth Rate of Immuno-oncology (2022-2029)
8.5 Microbiome Therapeutics Market Forecast Under COVID-19
9 Industry Outlook
9.1 Microbiome Therapeutics Market Drivers Analysis
9.2 Microbiome Therapeutics Market Restraints and Challenges
9.3 Microbiome Therapeutics Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Microbiome Therapeutics Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Microbiome Therapeutics Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Microbiome Therapeutics Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Thyroid Gland Disorders Treatment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 80
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 98
According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period.
The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
Global Enzyme Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 84
According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
Global Hormone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
